Researcher
Katrien Remaut
- Keywords:lipid nanoparticles, mRNA delivery, innate immunity, peritoneal carcinomatosis, non-viral gene delivery, ocular gene therapy
- Disciplines:Nanobiotechnology, Other biological sciences not elsewhere classified, Environmental safety and health of nanotechnology, Nanoscale characterisation, Nanotechnology not elsewhere classified, Nanophotonics, Nanometrology, Drug discovery and development not elsewhere classified, Clinical trials, Compound screening, Other pharmaceutical sciences not elsewhere classified, Biopharmaceuticals, In vitro testing, Non-clinical studies, Vaccines, Nanomaterials, Nanomanufacturing, Nanofabrication, growth and self assembly, Nanoelectromechanical systems
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Oct 2001 → Today
Infrastructure
1 - 1 of 1
- Confocal and two-photon Microscope (Consortium partner)
Projects
1 - 10 of 29
- ILM photodisruption: a biophotonic approach to promote retinal ganglion cell engraftment as a cure for blindnessFrom1 Nov 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Postdoctoral Fellowship Program in National Glaucoma Research: "“Exploring ICG-mediated ILM photodisruption as a tool to boost retinal ganglion cell engraftment"From1 Jul 2023 → TodayFunding: Foreign private sponsor - undefined
- Let There Be Light: two biophotonic approaches to boost retinal ganglion cell transplantation as a cure for blindnessFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Nanoparticle formulations of toll-like receptor agonists and oxaliplatin for local intraperitoneal delivery to treat colorectal peritoneal metastasisFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASESFrom1 Nov 2022 → TodayFunding: FWO research project (including WEAVE projects)
- In vivo evaluation of the expression kinetics and immunogenicity of lipid nanoparticle mediated messenger RNA and self-amplifying messenger RNA delivery to the retinaFrom18 Apr 2022 → 17 Apr 2023Funding: Foundations, funds and other with scientific goal
- Toekenning: ARVO Foundation for Eye Research and the Eye Bank Association of America EyeFind Research: "Grant Karen Peynshaert"From1 Feb 2022 → 31 Jan 2023Funding: Foreign Nonprofit organisations and equivalents
- Design of a novel antisense oligonucleotide therapy for inherited blindnessFrom1 Nov 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Intraperitoneal Aerosolized Liposomal Irinotecan (NalIRI) in Peritoneal Carcinomatosis from GI cancer: a phase I firstinhuman studyFrom1 Aug 2021 → TodayFunding: Private funding of national origin - undefined
- Genetic therapy for EYS- and USH2A-associated retinal dystrophy ("GET-READY")From1 Jun 2021 → TodayFunding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 90
- Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery : evaluation of the surface properties and effect on their distribution(2020)
Authors: P. S. Apaolaza, M. Busch, E. Asin-Prieto, Karen Peynshaert, R. Rathod, Katrien Remaut, N. Dünker, A. Göpferich
- Materials and technologies to combat counterfeiting of pharmaceuticals : current and future problem tackling(2020)
Authors: Heyang Zhang, Dawei Hua, Chaobo Huang, Sangram Keshari Samal, Ranhua Xiong, Félix Sauvage, Kevin Braeckmans, Katrien Remaut, Stefaan De Smedt
- Ocular barriers to retinal delivery of intravitreal liposomes : impact of vitreoretinal interface(2020)
Authors: Shirin Tavakoli, Karen Peynshaert, Tatu Lajunen, Joke Devoldere, Eva M. del Amo, Marika Ruponen, Katrien Remaut, Arto Urtti
Pages: 952 - 961 - Morphology and composition of the inner limiting membrane : species-specific variations and relevance toward drug delivery research(2019)
Authors: Karen Peynshaert, Joke Devoldere, An-Katrien Minnaert, Katrien Remaut
Pages: 465 - 475 - Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)(2019)
Authors: Leen Van de Sande, Wouter Willaert, Sarah Cosyns, Kaat De Clercq, Molood Shariati, Katrien Remaut, Wim Ceelen
- Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis(2019)
Authors: Molood Shariati, Wouter Willaert, Wim Ceelen, Stefaan De Smedt, Katrien Remaut
- High pressure nebulization (PIPAC) versus injection for the intraperitoneal administration of mRNA complexes(2019)
Authors: Molood Shariati, Heyang Zhang, Leen Van de Sande, Benedicte Descamps, Christian Vanhove, Wouter Willaert, Wim Ceelen, Stefaan De Smedt, Katrien Remaut
- Non-viral delivery of chemically modified mRNA to the retina : subretinal versus intravitreal administration(2019)
Authors: Joke Devoldere, Karen Peynshaert, Heleen Dewitte, Christian Vanhove, Lies De Groef, Lieve Moons, Sinem Yilmaz Özcan, Deniz Dalkara, Katrien Remaut
Pages: 315 - 330 - Müller cells as a target for retinal therapy(2019)
Authors: Joke Devoldere, Karen Peynshaert, Katrien Remaut
Pages: 1483 - 1498 - Photoablation of human vitreous opacities by light-induced vapor nanobubbles(2019)
Authors: Félix Sauvage, Juan Fraire, Katrien Remaut, J Sebag, Karen Peynshaert, Michael Harrington, Frans J Van de Velde, Ranhua Xiong, Marie-Jose Tassignon, Toon Brans, et al.
Pages: 8401 - 8416
Patents
1 - 2 of 2